CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Association of Cardiovascular Disease With Respiratory Disease Dapagliflozin for treating chronic heart failure with reduced ejection fraction The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure AIM2-driven inflammasome activation in heart failure A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review

Review ArticleVolume 41, Issue 12, 21 March 2020, Pages 1232–1248

JOURNAL:European Heart Journal Article Link

The year in cardiology: heart failure: The year in cardiology 2019

JGF Cleland, AR Lyon, T McDonagh et al. Keywords: HF; HFpEF; HFrEF

FULL TEXT PDF